MedDataX Logo

Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma

NCT ID: NCT05159817

Last Updated: 2023-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

19 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-15

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to prolong observational follow-up up to 36 months of patients already implanted with a novel interposition supraciliary implant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma

NCT03736655

Glaucoma, Open-Angle
TERMINATED NA

Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma

NCT05236439

Glaucoma, Open-Angle Glaucoma, Narrow Angle
ACTIVE_NOT_RECRUITING NA

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2)

NCT04770324

Glaucoma, Open-Angle
TERMINATED NA

Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study

NCT06612346

Open Angle Glaucoma
COMPLETED

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01517477

Primary Open Angle Glaucoma (POAG)
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

19 patients with primary open angle glaucoma (POAG) refractory to topical medical therapy were operated in late 2020 and a novel interposition supraciliary device implanted.

These patients reached 6 months follow-up and the original study had to be interrupted.

This observational study prolonges follow-up to 36 months

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma, Open-Angle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who were implanted in this center with the novel supraciliary interposition device under the scope of clinical trial NCT03736655

Exclusion Criteria

* if cannot assist to all future follow-up visits
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ciliatech

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Malayan Center

Yerevan, , Armenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Armenia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SAFARI FU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.
NCT07081347 ACTIVE_NOT_RECRUITING NA
Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra
NCT03255785 COMPLETED NA
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT05625958 RECRUITING NA
A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent
NCT01252914 COMPLETED PHASE4
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
NCT01455467 COMPLETED NA
A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.
NCT00326014 COMPLETED PHASE4
Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
NCT01456390 COMPLETED NA
Evaluation of the Xen Implant in Glaucoma Surgery
NCT03733600 COMPLETED
Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma
NCT04619654 COMPLETED NA
Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents
NCT01252862 COMPLETED PHASE4
Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents
NCT01252888 COMPLETED PHASE4
An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
NCT04872348 COMPLETED
Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
NCT01252849 COMPLETED NA
MIMS® Retrospective Chart Review
NCT06614218 NOT_YET_RECRUITING
Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma
NCT05892185 UNKNOWN NA
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
NCT06577857 RECRUITING
A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
NCT06809647 NOT_YET_RECRUITING NA
OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma
NCT06991270 RECRUITING NA
Evaluation of the Impact of the XEN® Implant on Endothelial Cell Density, 3 Years After Surgery
NCT05904613 COMPLETED
Study of OMNI System in OAG (GEMINI)
NCT03861169 COMPLETED NA
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
NCT05696561 NOT_YET_RECRUITING NA
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
NCT05044793 COMPLETED
Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy
NCT04586738 UNKNOWN NA
The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)
NCT07051174 COMPLETED NA
Hydrus Microstent as a Quality of Life Consideration
NCT05955118 UNKNOWN